← FDA Drug Approvals (Drugs@FDA)

TICAGRELOR

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 2026-08-20

Drug application

FDA Application #

ANDA218869

Application type

Abbreviated New Drug Application (Generic)

Brand name

TICAGRELOR

Generic name

TICAGRELOR

Active ingredients

TICAGRELOR

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMOBEDIENT

Manufacturer

Laurus Labs Limited

First approval

2026-08-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown